PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, The First Affiliated Hospital of University of Science and Technology of China, Hefei, 230001, Anhui, China.\', \'Infection Department, The First Affiliated Hospital of University of Science and Technology of China, Hefei, 230001, Anhui, China.\', \'Department of Pharmacy, Wuxi People\'s Hospital Attached to Nanjing Medical University, Wuxi, 214023, Jiangsu, China. qizhigang058518@163.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s40261-020-00917-3
?:hasPublicationType
?:journal
  • Clinical drug investigation
is ?:pmid of
?:pmid
?:pmid
  • 32337664
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.719
?:rankingScore_hIndex
  • 49
is ?:relation_isRelatedTo_publication of
?:title
  • Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all